This opportunity is closed.The response deadline was Mar 25, 2026.
Chemical and Biological Defense
Set-Aside
Total Small Business
Competition
Full And Open
Award Type
Firm Fixed Price
Period of Performance
unknown
Number of Awards
multiple
Develop an innovative immune microphysiological systems platform capable of evaluating vaccine immunogenicity and efficacy against high consequence pathogens. The system must incorporate advanced technologies such as immune organoids, organ-tissue equivalents, or microfluidic chips to serve as alternative methodologies for medical countermeasures development.
Categories
Estimated team size: 3-5
Delivery Type
R&D
Complexity
High
Remote Eligible
Hybrid
Travel
Minimal
Evaluation
Best Value
Submission Complexity
Sign in to view market intelligence, competition analysis, and spending data.
Sign InComplex
Incumbent Advantage
None
Protest Risk
Low
Follow-On Potential
Yes
Data Rights
Unlimited
Tech Stack
Certifications Required
Contract Vehicles Mentioned
Similar contracts that have recently closed — useful for research and frequency analysis.
Similar contracts are posted regularly. Set up alerts to get notified when matching contracts appear.
Get alerts for contracts like this →Browse more opportunities in this category to find your next bid.